Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/29711
Title: , Safety, Pharmacokinetics and Pharmacodynamics of Canakinumab in Patients With colchicine-resistant FMF: Results From the Phase 3 CLUSTER Trial
Authors: özen, S
Koné-Paut, I
Hofer, M
VAN DER HILST, Jeroen 
Gül, Ahmet
Brogan, Paul
Manna, Rafaelle
Issue Date: 2017
Source: 24th Pediatric Rheumatology Congress, Athens, Greece, 14/09/2017
Document URI: http://hdl.handle.net/1942/29711
DOI: 10.1186/s12969-017-0186-9
Category: C2
Type: Conference Material
Appears in Collections:Research publications

Files in This Item:
File Description SizeFormat 
published abstract canakinumab pediatric rheumatology.pdfConference material1.55 MBAdobe PDFView/Open
Show full item record

Page view(s)

52
checked on Sep 6, 2022

Download(s)

164
checked on Sep 6, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.